Amplia Therapeutics Limited

INNMF · OTC
Analyze with AI
9/30/2025
3/31/2025
9/30/2024
3/31/2024
Operating Activities
Net Income-$2,761-$3,758-$2,814-$3,374
Dep. & Amort.$24$42$43$43
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$12$67$40
Change in WC$0-$668$0-$2,045
Other Non-Cash-$2,318-$1,342$1,532$3,751
Operating Cash Flow-$5,055-$5,714-$1,172-$1,584
Investing Activities
PP&E Inv.-$17-$2-$0-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$36$0$0$0
Investing Cash Flow-$53-$2-$0-$2
Financing Activities
Debt Repay.$0$0-$1,508$0
Stock Issued$17,236$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$24$11,955$3,873-$688
Financing Cash Flow$17,212$11,955$2,365-$687
Forex Effect$386$65-$19$3
Net Chg. in Cash$12,491-$4,558$4,558-$2,271
Supplemental Information
Beg. Cash$6,782$4,558$0$5,657
End Cash$19,273$0$4,558$3,385
Free Cash Flow-$5,072-$5,715-$1,173-$1,587
Amplia Therapeutics Limited (INNMF) Financial Statements & Key Stats | AlphaPilot